BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33811460)

  • 21. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.
    Hwang DW; Jang JY; Lee SE; Lim CS; Lee KU; Kim SW
    Langenbecks Arch Surg; 2012 Jan; 397(1):93-102. PubMed ID: 20640860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
    Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
    Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.
    Hwang DW; Jang JY; Lim CS; Lee SE; Yoon YS; Ahn YJ; Han HS; Kim SW; Kim SG; Yun YK; Han SS; Park SJ; Lim TJ; Kang KJ; Sim MS; Choi SH; Heo JS; Choi DW; Hur KY; Lee DS; Yun SS; Kim HJ; Cho CK; Kim HJ; Yu HC; Cho BH; Song IS
    J Korean Med Sci; 2011 Jun; 26(6):740-6. PubMed ID: 21655058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review.
    Kadota Y; Shinoda M; Tanabe M; Tsujikawa H; Ueno A; Masugi Y; Oshima G; Nishiyama R; Tanaka M; Mihara K; Abe Y; Yagi H; Kitago M; Itano O; Kawachi S; Aiura K; Tanimoto A; Sakamaoto M; Kitagawa Y
    World J Surg Oncol; 2013 Mar; 11():75. PubMed ID: 23517520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas.
    Shin SH; Han DJ; Park KT; Kim YH; Park JB; Kim SC
    World J Surg; 2010 Apr; 34(4):776-83. PubMed ID: 20127242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
    Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
    Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it.
    Okada K; Imaizumi T; Hirabayashi K; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Kawaguchi Y; Tanaka M; Inokuchi S; Makuuchi H
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):516-22. PubMed ID: 20714841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of pancreas.
    Yoon SJ; Kim H; Lee O; Jung JH; Lim CS; Shin YC; Kwon W; Jang JY; Shin SH; Heo JS; Han IW
    Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
    Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can long-term follow-up strategies be determined using a nomogram-based prediction model of malignancy among intraductal papillary mucinous neoplasms of the pancreas?
    Hijioka S; Shimizu Y; Mizuno N; Hara K; Imaoka H; Mekky MA; Bhatia V; Nagashio Y; Hasegawa T; Shinagawa A; Sekine M; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
    Pancreas; 2014 Apr; 43(3):367-72. PubMed ID: 24622065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
    Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
    World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natural history of branch-duct type intraductal papillary mucinous neoplasms of the pancreas].
    Lee SH; Park JK; Woo SM; Yoo JW; Ryu JK; Kim YT; Yoon YB
    Korean J Gastroenterol; 2007 Jan; 49(1):24-30. PubMed ID: 18167430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of endoscopic ultrasonography findings to distinguish benign and malignant intraductal papillary mucinous neoplasm.
    Dong W; Zhen D; Xiaoyan W; Bin C; Ruifeng W; Shanyu Q; Zhuoran L; Kai S; Wenming W; Aiming Y; Xi W
    Surg Endosc; 2023 Jun; 37(6):4681-4688. PubMed ID: 36881188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgical management of intraductal papillary mucinous neoplasms].
    Jang JY
    Korean J Gastroenterol; 2008 Oct; 52(4):220-5. PubMed ID: 19077523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.